Literature DB >> 9481114

Short-chain fatty acids in ulcerative colitis.

Y I Kim1.   

Abstract

Short-chain fatty acids (SCFA), a by-product of anaerobic fermentation of undigested carbohydrates within the colon, are an important energy source for colonic epithelial cells. It has been proposed that ulcerative colitis, a chronic inflammatory condition of the colon, may result from a metabolic defect in SCFA oxidation in the colon and that this defect may be corrected by supraphysiologic luminal levels of SCFA in the colon. Clinical trials published to date suggest that topical SCFA provide an effective primary and/or adjunctive treatment in patients with mild to moderate distal ulcerative colitis at substantial cost savings and without significant side effects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9481114     DOI: 10.1111/j.1753-4887.1998.tb01654.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  9 in total

Review 1.  Intestinal microflora as a therapeutic target in inflammatory bowel disease.

Authors:  Keiichi Mitsuyama; Atsushi Toyonaga; Michio Sata
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

Review 2.  Impact of environmental and dietary factors on the course of inflammatory bowel disease.

Authors:  Eduard Cabré; Eugeni Domènech
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

3.  Protection by short-chain fatty acids against 1-beta-D-arabinofuranosylcytosine-induced intestinal lesions in germfree mice.

Authors:  M G Ramos; E A Bambirra; J R Nicoli; D C Cara; E C Vieira; J Alvarez-Leite
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

Review 4.  Comparative tolerability of treatments for inflammatory bowel disease.

Authors:  R B Stein; S B Hanauer
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

Review 5.  Importance of nutrition in inflammatory bowel disease.

Authors:  Alfredo José Lucendo; Livia Cristina De Rezende
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

6.  Targeted Delivery of Persulfides to the Gut: Effects on the Microbiome.

Authors:  Kearsley M Dillon; Holly A Morrison; Chadwick R Powell; Ryan J Carrazzone; Veronica M Ringel-Scaia; Ethan W Winckler; R McAlister Council-Troche; Irving C Allen; John B Matson
Journal:  Angew Chem Int Ed Engl       Date:  2021-01-29       Impact factor: 15.336

Review 7.  Role of Short Chain Fatty Acids and Apolipoproteins in the Regulation of Eosinophilia-Associated Diseases.

Authors:  Eva Maria Sturm; Eva Knuplez; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

Review 8.  Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease?

Authors:  L Kruidenier; H W Verspaget
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

9.  Effects of alternate-day fasting, time-restricted fasting and intermittent energy restriction DSS-induced on colitis and behavioral disorders.

Authors:  Xin Zhang; Qianhui Zou; Beita Zhao; Jingwen Zhang; Weiyang Zhao; Yitong Li; Ruihai Liu; Xuebo Liu; Zhigang Liu
Journal:  Redox Biol       Date:  2020-04-10       Impact factor: 11.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.